New Breast Cancer Drug Shows Promise at Lower Doses in Presurgical Trial
Camizestrant effectively reduces estrogen receptors and tumor growth at just 75mg daily with minimal side effects in breast cancer patients.
487 articles in this topic
Camizestrant effectively reduces estrogen receptors and tumor growth at just 75mg daily with minimal side effects in breast cancer patients.
New consensus on genetic testing for cancer drugs creates fresh questions about finding the right dose for each patient.
New research reveals how healthcare delivery systems themselves can function as powerful cancer treatments beyond traditional drugs.
New research reveals how blood-brain barrier differences affect immunotherapy access, potentially improving brain cancer treatment.
New research reveals how brain barrier variations affect cancer treatment delivery, potentially improving outcomes.
Scientists develop CAR T cells that attack tumor-supporting immune cells, showing promise for treating hard-to-target solid cancers.
Engineered immune cells target harmful macrophages in tumors, transforming the cancer environment to boost natural anti-tumor immunity.
Scientists discover IGSF11-VISTA pathway as promising target for deadly childhood brain tumors, offering hope for new treatments.
New research reveals how the immune system can prevent melanoma metastasis by changing how lymphatic vessels function and metabolize energy.
New AI system delivers accurate cancer treatment information without hallucinations by linking to verified academic databases.
New research reveals how cancer in lymph nodes creates widespread immune suppression, making distant metastasis easier.
Revolutionary cancer drugs targeting KRAS mutations offer hope but resistance emerges quickly, spurring next-generation treatments.